AAPS Elects New President for 2017
The American Association of Pharmaceutical Scientists (AAPS) announced the election of Dale Eric Wurster, PhD, FAAPS as president-elect of its board of directors.
On August 8, 2017, the American Association of Pharmaceutical Scientists (AAPS) announced the election of Dale Eric Wurster, PhD, FAAPS as president-elect of the association’s board of directors. Starting in November 2017 at the AAPS Annual Meeting and Exposition in San Diego, CA, he will begin a three-year term as president-elect, president and immediate past president. The meeting anticipates an attendance of over 6,500 international pharmaceutical scientists.
“I am heavily invested in the long-term success of AAPS, and I would like very much to be part of the strategizing being undertaken by the leadership team as it attempts to create an even more active and vibrant scientific organization; an organization which will be relevant to academically-diverse individuals well into the 21st century,” said Dr. Wurster in his election bulletin.
In addition to the new president-elect, Reina Bendayan, PharmD, FAAPS from University of Toronto, and Allen C. Templeton, PhD, FAAPS from Merck & Co. were elected as AAPS Members-at-Large.
Source: AAPS
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Understanding the Variability in Bioburden Test Results in Biomanufacturing
May 7th 2025This article explores the impact of test volume, microbial distribution, and dilution errors on bioburden testing variability. It presents statistical approaches to estimate percentage error and discusses strategies to optimize microbial enumeration techniques in biopharmaceutical quality control.
